ARCPF (ARCpoint) Quick Ratio: 0.05 (As of Dec. 2025) — 95% Below Median


What is ARCpoint Quick Ratio?

ARCpoint ARCPF -56.33% Quick Ratio is 0.05 as of Dec. 2025, which is 95% below its 10-year median of 1.02. The stock has 6 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, ARCpoint ranks worse than 97.67% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. ARCpoint's quick ratio for the quarter that ended in Dec. 2025 was 0.05.

ARCpoint has a quick ratio of 0.05. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for ARCpoint's Quick Ratio or its related term are showing as below:

ARCPF' s Quick Ratio Range Over the Past 10 Years
Min: 0.05   Med: 1.02   Max: 2.92
Current: 0.05

During the past 7 years, ARCpoint's highest Quick Ratio was 2.92. The lowest was 0.05. And the median was 1.02.

ARCPF's Quick Ratio is ranked worse than
97.67% of 215 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.67 vs ARCPF: 0.05

ARCpoint  (OTCPK:ARCPF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


ARCpoint Quick Ratio Related Terms


ARCpoint Quick Ratio Historical Data

* Premium members only.

The historical data trend for ARCpoint's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ARCpoint Quick Ratio Chart

ARCpoint Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Quick Ratio
Get a 7-Day Free Trial 2.41 1.83 0.39 0.09 0.05

ARCpoint Quarterly Data
Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.08 0.06 0.06 0.05

ARCPF vs TMO, DHR, IDXX: Quick Ratio Comparison

For the Diagnostics & Research subindustry, ARCpoint's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ARCpoint Quick Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ARCpoint's Quick Ratio distribution charts can be found below:

* The bar in red indicates where ARCpoint's Quick Ratio falls into.



ARCpoint Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

ARCpoint's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Quick Ratio (A: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.442-0)/9.391
=0.05

ARCpoint's Quick Ratio for the quarter that ended in Dec. 2025 is calculated as

Quick Ratio (Q: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.442-0)/9.391
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 0.05 mean?
ARCpoint (ARCPF) has a Quick Ratio of 0.05 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on ARCpoint and its competitors. This is 95% below median its historical median of 1.02. Over the past decade, ARCpoint's Quick Ratio has ranged from 0.05 to 2.92. According to the industry distribution chart, ARCpoint ranks #210 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 97.7%.
Is ARCpoint's Quick Ratio too high?
ARCpoint's current Quick Ratio of 0.05 is 95% below median its 10-year median of 1.02. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 2.92. The Medical Diagnostics & Research industry median Quick Ratio is 1.67. ARCpoint's value of 0.05 is 97% below this industry median. Based on the distribution chart, ARCpoint ranks #210 out of 215 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does ARCpoint's Quick Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, ARCpoint ranks #210 out of 215 companies for Quick Ratio. This places ARCpoint in the lower half of its industry. The industry median Quick Ratio is 1.67. ARCpoint's value of 0.05 is 97% below this benchmark. Historically, ARCpoint's own Quick Ratio has ranged from 0.05 to 2.92 over the past decade. While the company's 10-year median is 1.02 vs. the industry median of 1.67, ARCpoint has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.67, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ARCpoint's current Quick Ratio of 0.05 is 97% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on ARCpoint and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ARCpoint's current Quick Ratio is 0.05, which is 95% below median its own 10-year median of 1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ARCpoint stock overvalued right now?
Based on GuruFocus' analysis, ARCpoint (ARCPF) is currently considered Fairly Valued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading right at its estimated fair value. The current Quick Ratio is 0.05, which is 95% below median its 10-year median of 1.02 and 97% below the Medical Diagnostics & Research industry median of 1.67. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For ARCpoint (ARCPF), the current Quick Ratio is 0.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ARCpoint Business Description

Other Exchanges ARC:Canada
Address 101 North Main Street, Suite 301, Greenville, SC, USA, 29601
ARCpoint Inc is a U.S-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing, corporate wellness programs, and employment and background screening, among other services. The platform also digitalizes and streamlines administrative functions such as materials purchasing, compliance, billing, and physician services for ARCpoint franchise labs and other clients.